Category

UF Startup

UF Startup Shadow Health Is Going Big and Staying Home

In early December, local UF startup Shadow Health, which develops virtual simulations for nursing and healthcare education, became part of Elsevier, a global leader in information and analytics, that is part of RELX, an even larger global provider of information-based analytics. The acquisition will hasten Shadow Health’s ability to reach its biggest goals.

Putting Drones and Smart AI to Work

Dr. Yiannis Ampatzidis and Matt Donovan are the developers of Agroview, a Florida startup invention and a 2020 Cade Prize finalist. A spinoff company located at UF Innovate | The Hub called “Agriculture Intelligence Inc.,” was created, which provides Agroview’s services to growers.

SharpSpring Announces Winning Three New TrustRadius Awards

UF startup SharpSpring, Inc., a leading cloud-based sales and marketing automation platform, announced that it has been named first place for Best Usability, Best Feature Set Award and Best Customer Support on TrustRadius, a B2B software technology review platform.

VetGuardian Is Working on Wireless Veterinary Care

Vik Ramprakash, CEO of UF startup Structured Monitoring Products Inc, has developed a solution called VetGuardian, a wireless device that sits a few feet away from the animal and requires no connection points to monitor the animal's vitals.

COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials

Supporting our troops: an Alachua company works to keep our soldiers safe from COVID-19. Here's what UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), is doing on the front lines of the pandemic.

Ology Bioservices Signs Built-to-Suit Lab Space, Adding 43,000 Square Feet to Headquarters

Avison Young facilitated a 42,500-square-foot lease agreement between Concept Companies and Ology Bioservices, a UF startup and UF Innovate | Sid Martin Biotech alum, for a new built-to-suit lab space on the heels of a federal government contract for the company to expand production capabilities, including vaccines and therapeutics for COVID-19 once finalized.

Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical Program, Two Preclinical Assets, and Novel Capsid Development for Ocular Diseases

UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced it has closed an oversubscribed $55 million Series A financing led by Sofinnova Investments with participation from additional new investors Abingworth and Lightstone Ventures.